Cargando…
The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study
PURPOSE: Metastatic neuroendocrine tumors secrete serotonin and other vasoactive substances that are responsible for carcinoid syndrome and carcinoid heart disease. We sought to evaluate the discriminatory utility of diagnostic biomarkers in determining the presence and severity of carcinoid heart d...
Autores principales: | Dobson, Rebecca, Burgess, Malcolm I., Banks, Melissa, Pritchard, D. Mark, Vora, Jiten, Valle, Juan W., Wong, Christopher, Chadwick, Carrie, George, Keith, Keevil, Brian, Adaway, Joanne, Ardill, Joy E. S., Anthoney, Alan, Hofmann, Uschi, Poston, Graeme J., Cuthbertson, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771983/ https://www.ncbi.nlm.nih.gov/pubmed/24069222 http://dx.doi.org/10.1371/journal.pone.0073679 |
Ejemplares similares
-
Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality
por: Dobson, R, et al.
Publicado: (2014) -
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
por: Ramage, John K, et al.
Publicado: (2011) -
SUN-222 Pre- and Post-Pubertal Reference Ranges for Oxygenated Androgens in Saliva
por: Adaway, Joanne, et al.
Publicado: (2020) -
Peptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity
por: Vinjamuri, S, et al.
Publicado: (2013) -
Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)